OHRP Update Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research Protections 3 rd Annual Medical Research Summit.

Slides:



Advertisements
Similar presentations
Advanced Issues in HIPAA Research Compliance The Sixth National HIPAA Summit March 27, 2003 Kim P. Gunter Senior Consultant.
Advertisements

TISSUE BANKING Challenging to Say the Least
Office for Protection from Research Risks (OPRR) Department of Health and Human Services National Institutes of Health OPRR Dissolved June, 2000.
Health Insurance Portability Accountability Act of 1996 HIPAA for Researchers: IRB Related Issues HSC USC IRB.
1 OHRP: Activities, Staffing, and Budget Ivor Pritchard, Ph.D. Senior Advisor to the Director Office for Human Research Protections (OHRP)
Research Involving Humans! OHRP- Office For Human Subject Protections
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
IRB-Investigator/ Research Coordinator Mtg. “What You Can Do to Facilitate an Efficient IRB Review” January 13, 2004 George Gasparis.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Human Subjects Protection in Research Carnegie Mellon University Regulatory Compliance Administration 5000 Forbes Avenue, UTDC Bldg., Rooms 108 & 109 Pittsburgh,
IRB Monthly Investigator Meeting Columbia University Medical Center IRB October 11, 2005.
1 Developed by: U-MIC To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the.
Human Investigation Committee  Is it research?  If yes, does it involve human subjects?  If yes, can it be exempt?  If no, will a Request for.
Federalwide Assurance Presentation for IRB Members.
Educational Research and the VCOM Institutional Review Board
Research Involving Human and Animal Subjects Tryn Stimart, MS. ATP Human and Animal Subjects Advisor.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Primary Care and Community Outreach Research VCOM Institutional Review Board Jim Mahaney, PhD Associate Dean for Biomedical Affairs, Virginia Campus Past.
OHRP Update Ivor Pritchard, Ph.D. Senior Advisor to the Director of OHRP May 2, 2015.
1 Defense Health Agency Privacy and Civil Liberties Office HIPAA Privacy Board Overview August 6, 2015.
HIPAA and Research Basics for IRB Tim Atkinson Director, Research and Sponsored Programs Director, Institutional Review Board Research Privacy Officer.
HIPAA – How Will the Regulations Impact Research?.
Confidentiality, Research, & Law
The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager.
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
HIPAA SURVIVAL SKILLS: An Update University of Miami1 Marisabel Davalos, M.S.Ed., CIP Associate Director of Educational Initiatives November, 2008.
Privacy and Confidentiality. Definitions n Privacy - having control over the extent, timing, and circumstances of sharing oneself (physically, behaviorally,
The Institutional Review Board: A Community College Toolkit Dr. Geri J Anderson.
Understanding HIPAA (Health Insurandce Portability and Accountability Act)
CCAS Annual Conference: New Orleans, LA November 11, 2010 The Role of Deans: Regulatory & Administrative Responsibilities Michelle Feige, MSW Public Health.
Status of SACHRP Recommendations July 2003-October 2008 Meeting of the Secretary’s Advisory Committee on Human Research Protections October 27, 2008 Michael.
The NCI Central IRB Initiative Third Annual Medical Research Summit Washington, D.C. March 2003.
VHA Handbook What’s new. General Requirements for Informed Consent A Legally Authorized Representative may not always qualify as a ‘personal representative’
OHRP Guidance and Policy Development Process Secretary’s Advisory Committee on Human Research Protections Meeting October 27, 2008 Irene Stith-Coleman,
OBSERVED IN ORO REVIEWS COMPLIANCE ISSUES: OBSERVED IN ORO REVIEWS David A. Weber, Ph.D., FACNP Acting Chief Officer Office of Research.
HIPAA Privacy for Pharma Audioconference 5/29/2002 pwC.
HIPAA and Human Subjects Research IRB Member CE May 2014 Slideshow by Sean Horkheimer.
OHRP’s Compliance Oversight Procedures
Medical Research in Times of Bioterrorism - OHRP’s Perspective Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Legal Responsibilities for Studies Conducted or Supported by HHS Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research.
Human Subjects Update E. Wethington, Chair, UCHS.
Final HIPAA Privacy Rule: The Research Provisions Julie Kaneshiro DHHS Office for Human Research Protections Phone: Fax:
HIPAA and RESEARCH 5 th Thursday May 31, Page 2.
Cancer Clinical Trials Office Clinical Trials & Research Training Oct2014.
HIPAA 2017 JHSPH IRB Clarifications and Changes
Conditional IRB Approval
Research Compliance and Institutional Review Boards
HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA)
The HIPAA Privacy Rule: Implications for Medical Research
Beverley Alberola, CIP Associate Director, Research Protections
HIPAA Administrative Simplification
IRB – Human subjects research incoming staff orientation 2017
Updates to Expedited Review Procedures
Updates to Expedited Review Procedures
KC IRB Implementation – Phase IV
Overview - Introduction
Overview of Changes to the Common Rule
Disability Services Agencies Briefing On HIPAA
Understanding the Planned Changes to the Federal Policy on Protection of Human Subjects (the Common Rule) Megan Kasimatis Singleton, JD, MBE, CIP Assistant.
Updates to Expedited Review Procedures
Secondary Research with Identifiable Information and Biospecimens
Expedited Status Update January 14, 2019
National Congress on Health Care Compliance
Making Your IRBs and Clinical Investigators HIPAA-Ready
Everything You Wanted to Know about UOPX IRB
HHS Reporting Requirements and Adverse Events
IRB Harmonization 2016 Review
The Second Annual Medical Research Summit
IRB submissions for researchers
Research with Human Subjects
Presentation transcript:

OHRP Update Michael A. Carome, M.D. Associate Director for Regulatory Affairs Office for Human Research Protections 3 rd Annual Medical Research Summit March 5-7, 2003 Washington, D.C.

OHRP Update - Presentation Overview Staff changes Federalwide Assurance (FWA) - electronic submission 45 CFR part 46 and HIPAA Updated guidance IRB Registration – pending notice of proposed rulemaking

OHRP Staff Changes Dr. Bernard Schwetz, Acting Director, OHRP Dr. Kristina Borror, Director, Division of Compliance Oversight Ms. Shirley Hicks, Acting Director, Division of Education and Development

Web-Based Electronic Submission of Federalwide Assurance (FWA) Must have an address Will expedite FWA processing by OHRP Must still mail in original signatory page Approval notification sent by IRB registration will be web-based soon

OHRP, 45 CFR Part 46, and HIPPA (1) General comment: The HIPAA Privacy Rule does not preempt any requirements of 45 CFR part 46 and vice versa. In situations where both rules are applicable, institutions must adhere to both sets of regulations. Will OHRP assess compliance with the requirements of the HIPAA Privacy Rule during its compliance oversight evaluations?

OHRP, 45 CFR Part 46, and HIPPA (2) When must an IRB review and approve patient authorizations for use or disclosure of protected health information related to human subjects research activities in order to satisfy requirements of 45 CFR part 46?

OHRP, 45 CFR Part 46, and HIPPA (3) The preparatory to research provision of the HIPAA Privacy Rule addresses certain circumstances in which seeking patient authorization for use or disclosure of protected health information is not required, nor is obtaining Privacy Board or IRB waiver of patient authorization required. When do the requirements of 45 CFR part 46 related to IRB review and informed consent apply to such activities?

OHRP Guidance Updates (1) New or recently updated guidance: –Written IRB procedures (7/2002) –Continuing review (7/2002) –Certificates of confidentiality (2/2003) –Fetal tissue transplantation research (2/2003) New documents are flagged as “NEW” on the “Guidance Topics by Subject” page (

OHRP Guidance Updates (2) Outdated documents on the “OPRR Reports ‘Dear Colleagues Letters’” page ( are labeled as “Archived.” “Archived documents” page (

OHRP Regulatory Update On December 9, 2002, HHS published in FR in its Unified Agenda notice of proposed rulemaking proposing to add subpart F to 45 CFR part 46, IRB Registration requirements (67 FR 74523) Registration would require: approximate number of active protocols, accreditation, and staffing

OHRP Updates Subscribe to OHRP Listserv